Martina Gabriele

Azienda Ospedaliero-Universitaria Careggi — Italy

Biochemistry, Genetics and Molecular Biology · Life Sciences

9h-index297citations19works0.02yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Amyloidosis: Diagnosis, Treatment, Outcomes(12), Parathyroid Disorders and Treatments(7), Cardiac Valve Diseases and Treatments(4), Cardiomyopathy and Myosin Studies(4), Cardiovascular Function and Risk Factors(3)

Publications19 total

Multi-Dimensional Evaluation in Patients With Aortic Stenosis who Are Candidates For Cardiac Surgery
Cardiovascular revascularization medicine·2023
P293 MULTI–DIMENSIONAL EVALUATION IN PATIENTS WITH AORTIC STENOSIS CANDIDATE FOR CARDIAC SURGERY
European Heart Journal Supplements·2023Open Access
CRT-400.16 Multi-Dimensional Evaluation in Patients With Aortic Stenosis who Are Candidates For Cardiac Surgery
JACC: Cardiovascular Interventions·2023
Anxious/Depressive Symptoms Alter the Subjective Perception of Heart Failure Severity in Transthyretin Cardiac Amyloidosis
The American Journal of Cardiology·2023· 7 citedOpen Access
Safety and efficacy of ranolazine in hypertrophic cardiomyopathy: Real-world experience in a National Referral Center
International Journal of Cardiology·2022· 12 cited
Red flags for the diagnosis of cardiac amyloidosis: simple suggestions to raise suspicion and achieve earlier diagnosis
Journal of Cardiovascular Medicine·2022· 10 cited
Sex-related differences in clinical presentation and all-cause mortality in patients with cardiac transthyretin amyloidosis and light chain amyloidosis
International Journal of Cardiology·2022· 27 citedOpen Access
110 Sex-related differences in clinical presentation and outcome of patients with cardiac transthyretin amyloidosis and light chain amyloidosis
European Heart Journal Supplements·2021Open Access
Early Diagnosis and Outcome in Patients With Wild-Type Transthyretin Cardiac Amyloidosis
Mayo Clinic Proceedings·2021· 36 cited
Pathophysiology and Treatment of Hypertrophic Cardiomyopathy: New Perspectives
Current Heart Failure Reports·2021· 36 cited
Changes in the perceived epidemiology of amyloidosis: 20 year-experience from a Tertiary Referral Centre in Tuscany
International Journal of Cardiology·2021· 37 citedOpen Access
Ventricular tachyarrhythmias and sudden cardiac death in light‐chain amyloidosis: a clash of cardio‐toxicities?
British Journal of Haematology·2021· 9 citedOpen Access
Tenosynovial complications identify TTR cardiac amyloidosis among patients with hypertrophic cardiomyopathy phenotype
Journal of Internal Medicine·2020· 30 citedOpen Access
Baseline ECG Features and Arrhythmic Profile in Transthyretin Versus Light Chain Cardiac Amyloidosis
Circulation Heart Failure·2020· 58 citedOpen Access
Biomarkers and Prediction of Prognosis in Transthyretin-Related Cardiac Amyloidosis: Direct Comparison of Two Staging Systems
Canadian Journal of Cardiology·2019· 33 cited
P2732Prevalence of electrocardiographic abnormalities in patients with cardiac amyloidosis
European Heart Journal·2019
P2728Prognostic impact of left atrial function in patients with cardiac amyloidosis: a cardiac magnetic resonance study
European Heart Journal·2019
P387Chest pain and mild left ventricular hypertrophy: a challenging diagnosis
European Heart Journal - Cardiovascular Imaging·2019Open Access
O-017 Natural progesterone administered vaginally does not reverse the beneficial effects of E2 on exercise induced myocardial ischemia and may have a beneficial action of its own
Fertility and Sterility·1997· 2 citedOpen Access

Frequent Co-authors

Francesco Cappelli(15), Carlo Di Mario(14), Iacopo Olivotto(12), Federico Perfetto(12), Mattia Zampieri(10), Raffaele Martone(6), Giulia Taborchi(6), Niccolò Marchionni(6), Marco Allinovi(6), Carlo Fumagalli(6), Alessia Argirò(6), Sofia Morini(5), Giulia Nardi(5), Chiara Zocchi(5), Luigi Tassetti(5), Alessia Tomberli(5), Elisa Vignini(4), Simone Bartolini(4), Martina Berteotti(4), Pierluigi Stefàno(4)